Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti–Vascular Endothelial Growth Factor Agents
2019 · Ophthalmology Retina · 25 citations
https://doi.org/10.1016/j.oret.2019.03.013
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
92
Papers
1.3K
Citations
20
h-index
26
i10-index
David Xu is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Retinal Diseases and Treatments & Retinal and Optic Conditions & Retinal Imaging and Analysis. The author has an h-index of 20, co-authored 79 publications.
ORCID: 0000-0003-3649-4746https://doi.org/10.1016/j.oret.2019.03.013
https://doi.org/10.1016/j.ophtha.2024.06.021
https://doi.org/10.1186/1749-8090-10-s1-a100
Click to start Chat